Status:
COMPLETED
Comparison of Subconjuctival Versus Topical Bevacizumab as Adjunct Therapy to Trabeculectomy
Lead Sponsor:
Sudhalkar Eye Hospital
Conditions:
Complications of Treatment
Progression
Eligibility:
All Genders
42+ years
Phase:
NA
Brief Summary
Bevacizumab is an anti vascular endothelial growth factor(anti-VEGF) substance that is known to reduce neovascularization and fibrovascular proliferation in inflammatory conditions, including post-ope...
Eligibility Criteria
Inclusion
- Primary Open Angle Glaucoma
- Progression
- Failure to reach target IOP
- Non compliant
Exclusion
- Resurgery
- Systemic contraindication to bevacizumab
- All other forms of glaucoma
Key Trial Info
Start Date :
December 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT01425112
Start Date
December 1 2007
End Date
June 1 2011
Last Update
August 29 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.